跳转到主要内容

Certara 公布 2023 年第四季度财报

Provides Full Year 2024 Financial Guidance PRINCETON, N.J.— 2024 年 2 月 29 日– Certara, Inc. (纳斯达克股票代码:CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter of fiscal year 2023. Fourth Quarter Highlights: “We are encouraged by our strong fourth quarter results, driven by improved execution across both software and services,” said William … Continued

Simcyp 群体模拟器中 PBPK 建模复合文件开发指南

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation. It links in vitro data to in vivo absorption, distribution, metabolism, excretion and pharmacokinetic/pharmacodynamic outcomes to explore clinical scenarios and …

RAPS: 生成式人工智能将如何使您的法规和医学撰写项目更上一层楼?

Drug developers face increasing pressures to accelerate the drug development process, including reducing submission timelines. Organizations are answering the challenge by evolving their authoring processes and leveraging technology efficiencies. For example, lean authoring techniques that incorporate structured content reuse can streamline the creation of complex regulatory documents. Tools that incorporate generative artificial intelligence (AI) can … Continued

靶向放射治疗的剂量优化考量

The acquisitions of targeted radiation therapy companies (TRT) Point Biopharma by Eli Lilly and RayzeBio by Bristol Meyer Squibb have sparked investors’ interest in this therapeutic class. A growing number of companies are now developing TRTs, and GlobalData reports that venture capital deals in the field have grown 550% to $408 million in 2023.1 The … Continued

2 页,共 47 页

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software